Belluna×Scroll×Pharma Foods International×Senshukai
Different ways of making money, on the same scale.
Same yardstick
| Metric | BellunaFY ending Mar 2026 | ScrollFY ending Mar 2025 | Pharma Foods InternationalFY ending Jul 2025 | SenshukaiFY ending Dec 2025 |
|---|---|---|---|---|
| Revenue | ¥218.1B | ¥84B | ¥65.3B | ¥42.1B |
| COGS ratio | 37.1% | 58.8% | 19.4% | 49.3% |
| Operating margin | 7.6% | 7.2% | 3.6% | -6.2% |
| Net margin | 5.3% | 5.1% | 0.6% | 9.4% |
| FCF margin | -6.9% | 6.9% | -3.1% | -8.4% |
Highlighted = best value for that metric
Compare industry percentiles by axis
Each row uses the same 0–100 scale. Dots show each company's rank within its primary industry.
- BellunaPrimary industry: Catalog & TV Shopping
- ScrollPrimary industry: Catalog & TV Shopping
- Pharma Foods InternationalPrimary industry: Catalog & TV Shopping
- SenshukaiPrimary industry: Catalog & TV Shopping
CompanyRank
Revenue growth
- Belluna509 peers
- Scroll38.99 peers
- Pharma Foods International83.39 peers
- Senshukai5.69 peers
- Belluna
Profitability
- Belluna7510 peers
- Scroll6510 peers
- Pharma Foods International3510 peers
- Senshukai510 peers
- Belluna
Cash conversion
- Belluna72.29 peers
- Scroll61.19 peers
- Pharma Foods International27.89 peers
- SenshukaiN/A
- Belluna
Efficiency
- Belluna510 peers
- Scroll5510 peers
- Pharma Foods International8510 peers
- Senshukai7510 peers
- Belluna
Financial strength
- BellunaN/A
- ScrollN/A
- Pharma Foods InternationalN/A
- SenshukaiN/A
- Belluna
Each dot is a company's percentile within its primary industry; peer groups may differ. Missing axes are labeled as unavailable. No combined score is calculated, and industry rank is not an investment recommendation.
Money flows side by side
Chart height is proportional to revenue.
Belluna¥218.1B · keeps ¥8 per ¥100
Scroll¥84B · keeps ¥7 per ¥100
Pharma Foods International¥65.3B · keeps ¥4 per ¥100
Senshukai¥42.1B · keeps ¥-6 per ¥100
Analyze this page with AI
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.